Dentium CO., LTD (KRX:145720)

Market Cap	232.02B -51.7%
Revenue (ttm)	348.09B -6.5%
Net Income	30.12B -42.9%
EPS	3,510.42 -51.0%
Shares Out	6.18M
PE Ratio	10.70
Forward PE	5.32
Dividend	600.00 (1.60%)
Ex-Dividend Date	Mar 20, 2026

Volume	8,548
Open	37,900
Previous Close	37,250
Day's Range	37,300 - 38,000
52-Week Range	35,000 - 60,600
Beta	0.61
Analysts	Strong Buy
Price Target	67,400.00 (+79.49%)
Earnings Date	Nov 6, 2026

About Dentium CO., LTD

Dentium CO., LTD manufactures and sells dental medical instrument worldwide. Its implant systems include superline, implantium, implantium 2, N.R. line, simple line 2, and slim line. The company also provides block and coloring; regeneration products; and digital dentistry products. In addition, it offers orthodontics, bright resin, tooth care, and other dental products. The company was formerly known as Biostech Co., Ltd. and changed its name to Dentium Co.,Ltd. in August 2002. Dentium Co.,Ltd. was founded in 2000 and is headquartered in Seoul...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 2000
• Employees: 853
• Stock Exchange: Korea Stock Exchange
• Ticker Symbol: 145720

Financial Performance

In 2025, Dentium CO., LTD's revenue was 346.45 billion, a decrease of -15.05% compared to the previous year's 407.81 billion. Earnings were 16.41 billion, a decrease of -77.43%.

Analyst Summary

According to 5 analysts, the average rating for 145720 stock is "Strong Buy." The 12-month stock price target is ₩67,400, which is an increase of 79.49% from the latest price.

Price Target

₩67,400

(79.49% upside)

Analyst Consensus: Strong Buy

Data Sources: S&P Global Market Intelligence and Twelve Data

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Twelve Data.

Last checked:

Sep 4, 2026

Data Sources Report a data error